 clinic implic pathophysiolog chang midlif hypertens patient hypertens decreas cardiac output stroke volum diminish beta-adrenerg respons parallel vascular resist increas vascular hypertrophi addit hypertens alpha-adrenerg respons age hypertens increas plasma cholesterol insulin valu alter cholesterol insulin level middle-ag patient hypertens alpha-adrenergic-block agent posit effect lipid insulin resist shift enhanc alpha-adrenerg respons fact vasodil exercis perform favor use alpha-block first drug middle-ag patient hypertens blood pressur paramount goal compound efficaci individu patient